Centene (NYSE:CNC – Get Free Report) is expected to be posting its Q4 2025 results before the market opens on Friday, February 6th. Analysts expect the company to announce earnings of ($1.25) per share and revenue of $48.4133 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 9:00 AM ET.
Centene (NYSE:CNC – Get Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.71. The business had revenue of $49.69 billion during the quarter, compared to analysts’ expectations of $47.50 billion. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The business’s revenue was up 18.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.62 earnings per share. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.
Centene Stock Up 3.8%
Shares of CNC opened at $43.50 on Friday. The firm has a market cap of $21.38 billion, a PE ratio of -4.02, a price-to-earnings-growth ratio of 0.97 and a beta of 0.48. Centene has a fifty-two week low of $25.08 and a fifty-two week high of $66.81. The company’s fifty day moving average is $41.72 and its two-hundred day moving average is $35.39. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.83.
Institutional Trading of Centene
Analyst Upgrades and Downgrades
CNC has been the topic of a number of analyst reports. Mizuho set a $47.00 price objective on Centene in a report on Friday, January 9th. Cantor Fitzgerald increased their target price on shares of Centene from $38.00 to $41.00 and gave the stock a “neutral” rating in a report on Thursday, October 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Morgan Stanley increased their price target on shares of Centene from $28.00 to $38.00 and gave the company an “equal weight” rating in a report on Tuesday, October 14th. Finally, Robert W. Baird increased their price target on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, Centene currently has a consensus rating of “Hold” and a consensus price target of $40.81.
Read Our Latest Research Report on CNC
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- What a Former CIA Agent Knows About the Coming Collapse
- Inside: Pre-IPO Ticker + The Next Elon Musk?
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Buy this Gold Stock Before May 2026
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
